---
title: "Acne Vulgaris: Clinical Guide for Healthcare Professionals"
slug: "acne-vulgaris-clinical-guide"
date: "2025-09-20"
tags: ["acne", "dermatology", "AAD-guidelines", "clinical"]
---

import { Tooltip } from "@/components/ui/Tooltip";
import { Collapsible, CollapsibleTrigger, CollapsibleContent } from "@/components/ui/Collapsible";
import { FlowDiagram, FlowNode } from "@/components/ui/FlowDiagram";

# Acne Vulgaris: Clinical Guide

**Reference:** 2024 AAD Guidelines of Care for the Management of Acne Vulgaris

---

<Collapsible>
  <CollapsibleTrigger>Summary</CollapsibleTrigger>
  <CollapsibleContent>
Acne vulgaris is a chronic skin condition most commonly affecting adolescents and young adults. Its etiology is multifactorial: genetic predisposition, hormonal effects on sebum production, bacterial colonization with <Tooltip content="Formerly Propionibacterium acnes">Cutibacterium acnes</Tooltip>, and follicular hyperkeratosis. Acne manifests as noninflammatory comedonal acne and/or inflammatory acne (papules, nodules), commonly on the face, shoulders, chest, and back. Diagnosis is clinical; studies are indicated only if an underlying condition (e.g., PCOS) is suspected. Pharmacological treatment is guided by severity and lesion type.
  </CollapsibleContent>
</Collapsible>

---

<Collapsible>
  <CollapsibleTrigger>Epidemiology</CollapsibleTrigger>
  <CollapsibleContent>
- Most prevalent chronic skin condition in the US (>50 million affected)  
- Age of onset: 11–12 years, usually resolves by 20–30 years  
- Sex: More common in adolescent males, adult females
  </CollapsibleContent>
</Collapsible>

---

<Collapsible>
  <CollapsibleTrigger>Etiology & Risk Factors</CollapsibleTrigger>
  <CollapsibleContent>
**Causes:**  
- Genetic predisposition  
- Hormonal: ↑ androgens → ↑ sebum; menstrual cycle fluctuations in women  
- Follicular hyperkeratosis → comedone formation  
- Bacterial colonization with <Tooltip content="Cutibacterium acnes promotes inflammation">C. acnes</Tooltip>  

**Risk Factors:**  
- Climate, drugs (steroids, anabolic), diet, stress, tobacco, cosmetics  
- Endocrine disorders: PCOS, congenital adrenal hyperplasia
  </CollapsibleContent>
</Collapsible>

---

<Collapsible>
  <CollapsibleTrigger>Clinical Features</CollapsibleTrigger>
  <CollapsibleContent>
**Common sites:** face, shoulders, upper chest, back  
**Types:**  
- Noninflammatory: open (blackheads) / closed comedones (whiteheads)  
- Inflammatory: papules, pustules, nodulocystic lesions (>5mm), acne conglobata  

**Severity:**  
- Mild: few comedones ± papules/pustules  
- Moderate: several comedones ± nodules  
- Severe: multiple comedones, inflammatory lesions, cysts
  </CollapsibleContent>
</Collapsible>

---

<Collapsible>
  <CollapsibleTrigger>Diagnosis</CollapsibleTrigger>
  <CollapsibleContent>
- Clinical diagnosis in most cases  
- Labs only if underlying pathology suspected (hyperandrogenism, refractory infection)  
- Routine testing for C. acnes not recommended
  </CollapsibleContent>
</Collapsible>

---

<Collapsible>
  <CollapsibleTrigger>Differential Diagnosis</CollapsibleTrigger>
  <CollapsibleContent>
- Gram-negative folliculitis  
- Pityrosporum folliculitis  
- Hidradenitis suppurativa  
- Rosacea, perioral dermatitis, pseudofolliculitis barbae
  </CollapsibleContent>
</Collapsible>

---

## Treatment Flow Diagram

<FlowDiagram>
  <FlowNode id="mild" label="Mild Acne" color="green">
    Topical therapy: benzoyl peroxide, retinoid, or combination
  </FlowNode>
  <FlowNode id="moderate" label="Moderate Acne" color="yellow">
    Topical therapy ± oral antibiotic, consider hormonal therapy (females)
  </FlowNode>
  <FlowNode id="severe" label="Severe Acne" color="red">
    Oral isotretinoin preferred; OR oral antibiotic + topical combination
  </FlowNode>
  <FlowNode id="reassess" label="Reassess in 4–6 weeks" color="blue">
    Adjust therapy or refer to dermatologist if poor response
  </FlowNode>
</FlowDiagram>

---

<Collapsible>
  <CollapsibleTrigger>Topical Pharmacotherapy</CollapsibleTrigger>
  <CollapsibleContent>
- Retinoids: anti-inflammatory, comedolytic; apply at night  
- Benzoyl peroxide: antimicrobial + anti-inflammatory; may combine with topical antibiotics  
- Topical antibiotics: clindamycin preferred, limit monotherapy to ≤12 weeks  
- Alternatives: azelaic acid, clascoterone, salicylic acid
  </CollapsibleContent>
</Collapsible>

---

<Collapsible>
  <CollapsibleTrigger>Oral Antibiotic Therapy</CollapsibleTrigger>
  <CollapsibleContent>
- Indicated for moderate-to-severe inflammatory acne  
- Always combine with topical therapy to prevent resistance  
- First line: tetracyclines (doxycycline, minocycline, sarecycline)  
- Limit duration <4 months
  </CollapsibleContent>
</Collapsible>

---

<Collapsible>
  <CollapsibleTrigger>Hormonal Therapy</CollapsibleTrigger>
  <CollapsibleContent>
- Antiandrogenic medications (COCs, spironolactone) for females with inflammatory acne  
- Consider corticosteroids for select patients  
- Evaluate contraindications and monitor for adverse effects
  </CollapsibleContent>
</Collapsible>

---

<Collapsible>
  <CollapsibleTrigger>Isotretinoin Therapy</CollapsibleTrigger>
  <CollapsibleContent>
- Indicated for severe, recalcitrant, or escalating moderate acne  
- Contraindicated: pregnancy, breastfeeding, females not using contraception  
- Monitor labs: liver, lipids; follow iPLEDGE program  
- Typical course: 15–20 weeks for cumulative 120–150 mg/kg  
- Adverse effects: cheilitis, dry skin, metabolic changes, rare fetal teratogenicity
  </CollapsibleContent>
</Collapsible>

---

<Collapsible>
  <CollapsibleTrigger>Maintenance Therapy</CollapsibleTrigger>
  <CollapsibleContent>
- Mild acne: topical retinoid  
- Moderate: retinoid + benzoyl peroxide  
- Severe: retinoid + benzoyl peroxide + antibiotic (topical/oral)  
- Clinical improvement usually in 4–6 weeks; clearing in 2–3 months
  </CollapsibleContent>
</Collapsible>

---

<Collapsible>
  <CollapsibleTrigger>Special Populations</CollapsibleTrigger>
  <CollapsibleContent>
**Infants:**  
- Neonatal cephalic pustulosis: self-limited, may use topical antifungals  
- Infantile acne: topical ± systemic therapy, prevent scarring  

**Pregnancy:**  
- Use only medications safe in pregnancy (azelaic acid, benzoyl peroxide, certain antibiotics)  
- Avoid retinoids, tetracyclines, hormonal therapies
  </CollapsibleContent>
</Collapsible>

---

### References

1. 2024 AAD Guidelines of Care for the Management of Acne Vulgaris  
2. Additional sources from US dermatology literature as cited in guidelines

---

